Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ETONOGESTREL
- Etonogestrel (ENG) Implant Insertion for Emergency Contraception With Oral Levonorgestrel (LNG) vs Placebo
- Tranexamic Acid to Reduce Contraceptive-related Bleeding Side Effects
- Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus
- Endometrial Biopsy in Progestin Contraceptive Users
- Effects of the Contraceptive Implant in Women With Sickle Cell Disease
- A Study to Evaluate the Effect of a Contraceptive Vaginal Ring LSP- 5415 on Ovarian Function in Healthy Adult Females
- Metabolism of 0.35mg Norethindrone vs 5mg Norethindrone Acetate
- Etonogestrel Implant as Emergency Contraception
- Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study
- Does Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?
- Pharmacokinetic Interactions of ENG Subdermal Implants With Long-Acting Cabotegravir (CAB-LA) and LA Rilpivirine (RPV-LA) (CARLA)
- Kuwa Free! - Live Free!
- Tamoxifen Versus Estradiol for Unscheduled Bleeding in Etonogestrel Implant Users, a Randomized Pilot Trial
- Premature Discontinuation of Contraceptive Implants
- Impact of Contraceptives on Cervico-Vaginal Mucosa
- Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa
- A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060)
- Shoulder Contraceptive Implant Study
- Rifampin and the Contraceptive Implant
- Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
- Ovarian Function With ENG Implant and UPA Use
- Use of Curcumin to Treat Unfavorable Bleeding Patterns in Contraceptive Implant Users
- Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing Implant
- Breastfeeding Etonogestrel Implant Study
- Hormonal Contraceptive Methods on Immunologic Changes in the Female Genital Tract (FGT) and Systemically
- Antepartum Etonogestrel Contraceptive Implant Insertion at Term
- Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
- Immediate Versus Delayed Insertion of Implanon in Postpartum Adolescents
- Abnormal Uterine Bleeding and Progestin-only Contraceptives
- Acceptability & Tolerance of Immediate Versus Delayed Postpartum Contraceptive Implant
- The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
- Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy
- Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
- Intervention to End Recurrent Unscheduled Bleeding Trial
- Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users
- Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis
- Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in the Treatment of Women With Primary Dysmenorrhea (MK-8342B-060)
- Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring (MK-8342B) in Women With Primary Dysmenorrhea (With Optional Extension) (MK-8342B-059)
- Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
- Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring and Levonorgestrel-Ethinyl Estradiol Combined Oral Contraceptive in Adult Women at Risk for Pregnancy (MK-8342B-062)
- Contraception in Women With Sickle Cell Disease
- The Female Sexual Functions With Progestogen-only Contraception
- Efficacy and Safety of Etonogestrel + 17β-Estradiol Vaginal Ring in Women at Risk for Pregnancy (MK-8342B-061)
- Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis
- Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development
- Impact of Hormonal Contraception on HIV Acquisition and Transmission Risk
- Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant
- A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy
- Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
- HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC
- Pharmacokinetics and Pharmacodynamics of the Etonogestrel Contraceptive Implant When Co-administered With Efavirenz
- Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study
- Treatment of Unacceptable Bleeding Patterns in ETG Implant Users With an Oral Contraceptive
- Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART
- Quantification of Immune Cells in Women Using Contraception (CHIC II)
- Immediate vs. Delayed Postpartum Etonogestrel Implant
- A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)
- A Study to Evaluate the Effect of Contraceptive Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)
- Postpartum Etonogestrel Implant for Adolescents
- Management of Etonogestrel Subdermal Implant-related Bleeding
- Contraceptive Pill and Hormonal Vaginal Ring in Women With Polycystic Ovary Syndrome
- Study of the Use of a Contraceptive Vaginal Ring (NuvaRing) in Normal Daily Practice in Indian Women (P07733)
- Effect of the Etonogestrel 0.12mg/Ethinyl Estradiol 0.015mg Vaginal Ring on Vaginal Innate and Inflammatory Biomarkers
- The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth
- Same-day Long-acting Reversible Contraception for Medication Abortion
- An Explorative Trial to Explore the Safety, Acceptability and Vaginal Bleeding Pattern of Three Etonogestrel-releasing Medicated Intrauterine Systems (Study P06060)
- Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
- Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women
- A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(P06473)(COMPLETED)
- Comparison of Serum Contraceptive Hormone Levels Between Normal Weight and Obese Users of the NuvaRing®
- A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(P05806)
- A Multicenter Trial to Evaluate the Insertion Characteristics of the Radiopaque Etonogestrel Implant Using a Next Generation Applicator (34530)(P05702)
- Hormonal Contraception and Vaginal Health
- Hormonal Contraception in Healthy Young Men (P42306)(COMPLETED)(P06057)
- Quick Start Initiation of the Contraceptive Vaginal Ring in Adolescents
Clinical trials list
click for details